Ausgabe 2/2016
Inhalt (12 Artikel)
Increasing radiation dose improves immunotherapy outcome and prolongation of tumor dormancy in a subgroup of mice treated for advanced intracerebral melanoma
Henry M. Smilowitz, Peggy L. Micca, Daniel Sasso, Qian Wu, Nathanial Dyment, Crystal Xue, Lynn Kuo
Neutrophil–lymphocyte ratio predicts survival in patients with advanced cholangiocarcinoma on chemotherapy
Ban Seok Lee, Sang Hyub Lee, Jun Hyuk Son, Dong Kee Jang, Kwang Hyun Chung, Yoon Suk Lee, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim
A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer
Masanori Noguchi, Fukuko Moriya, Noriko Koga, Satoko Matsueda, Tetsuro Sasada, Akira Yamada, Tatsuyuki Kakuma, Kyogo Itoh
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
Susanna Mandruzzato, Sven Brandau, Cedrik M. Britten, Vincenzo Bronte, Vera Damuzzo, Cécile Gouttefangeas, Dominik Maurer, Christian Ottensmeier, Sjoerd H. van der Burg, Marij J. P. Welters, Steffen Walter
Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery
Michael J. Campa, M. Anthony Moody, Ruijun Zhang, Hua-Xin Liao, Elizabeth B. Gottlin, Edward F. Patz Jr.
Favorable prognostic influence of T-box transcription factor Eomesodermin in metastatic renal cell cancer patients
Anastasia Dielmann, Anne Letsch, Anika Nonnenmacher, Kurt Miller, Ulrich Keilholz, Antonia Busse
IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells
Yosuke Ohno, Hidemitsu Kitamura, Norihiko Takahashi, Junya Ohtake, Shun Kaneumi, Kentaro Sumida, Shigenori Homma, Hideki Kawamura, Nozomi Minagawa, Susumu Shibasaki, Akinobu Taketomi
Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy
Anirudh Saraswathula, Elizabeth A. Reap, Bryan D. Choi, Robert J. Schmittling, Pamela K. Norberg, Elias J. Sayour, James E. Herndon II, Patrick Healy, Kendra L. Congdon, Gerald E. Archer, Luis Sanchez-Perez, John H. Sampson
Galectin-1 is associated with poor prognosis in patients with cutaneous head and neck cancer with perineural spread
Sharad Chawla, Timothy A. Warren, Leesa F. Wockner, Duncan L. J. Lambie, Ian S. Brown, Thomas P. C. Martin, Rajiv Khanna, Graham R. Leggatt, Benedict J. Panizza
Poly(I:C) potentiates Bacillus Calmette–Guérin immunotherapy for bladder cancer
Cherifa Ayari, Marjorie Besançon, Alain Bergeron, Hélène LaRue, Vanessa Bussières, Yves Fradet
8th Annual Canadian Cancer Immunotherapy Consortium (CCIC) Symposium 2015—May 20–22, Vancouver, Canada
Jeanette E. Boudreau, Maartje C. A. Wouters, Connie M. Krawczyk